The effect op corticosteroids on quality of life following total hip arthroplasty: HIPSTER study

Condition studied

Patients aged 60 years or older undergoing total hip arthroplasty

Investigational medicinal product(s)

Eligibility

Primary endpoint

Health-related quality of life (EQ-5D-5L) on day 30, 60 and 90 following surgery

Endpoint detail

Quality of recovery (QoR-15) on day 1, day 3, and day 5 following surgery, Health-related quality of life (EQ-VAS) on day 30, 60 and 90 following surgery, Oxford Hip Score (OHS) on day 30, 60 and 90 following surgery, Brief Pain Inventory (BPI) on day 30, 60 and 90 following surgery, Chalder fatigue questionnaire (CFQ) on day 30, 60 and 90 following surgery, Consensus Sleep Diary (CSD) starting 3 days before surgery until 5 days after surgery, Munich ChronoTypre Questionnaire (MCTQ) preoperatively, EEG reading during the first postoperative night (separate opt-in), Remote sleep pattern, sleep quality, and physical health monitoring using a wearable device (Oura Ring) during the first month postoperatively (separate opt-in), Montreal Cognitive Assessment (MoCA) on day 30 following surgery, PROMIS cognitive domain SF8a on day 30 following surgery